ES2186911T3 - Compuestos nucleotidico de fosfonato. - Google Patents

Compuestos nucleotidico de fosfonato.

Info

Publication number
ES2186911T3
ES2186911T3 ES97934776T ES97934776T ES2186911T3 ES 2186911 T3 ES2186911 T3 ES 2186911T3 ES 97934776 T ES97934776 T ES 97934776T ES 97934776 T ES97934776 T ES 97934776T ES 2186911 T3 ES2186911 T3 ES 2186911T3
Authority
ES
Spain
Prior art keywords
similar
rent
group
replaced
halogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97934776T
Other languages
English (en)
Inventor
Masaru Ubasawa
Kouichi Sekiya
Hideaki Takashima
Naoko Ueda
Satoshi Yuasa
Naohiro Kamiya
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Chemical Corp
Original Assignee
Mitsubishi Chemical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Chemical Corp filed Critical Mitsubishi Chemical Corp
Application granted granted Critical
Publication of ES2186911T3 publication Critical patent/ES2186911T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C07F9/65616—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing the ring system having three or more than three double bonds between ring members or between ring members and non-ring members, e.g. purine or analogs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

LA INVENCION SE REFIERE A UN COMPUESTO DE FOSFONATO DE NUCLEOTIDO, REPRESENTADO POR LA FORMULA (I): (DONDE R 1 ES UN GRUPO ALQUILO C 1 - C 6 O SIMILAR, R 2 ES UN ATOMO DE HIDROGENO, UN GRUPO ALQUILO C 1 - C 4 SUSTITUIDO POR UNO O MAS ATOMOS DE HALOGENO O SIMILARES, R 3 ES UN ATOMO DE HIDROGENO, UN GRUPO ALQUILO C 1 - C 4 SUSTITUIDO POR UNO O MAS ATOMOS DE HALOGENO O SIMILARES, R 4 ES UN ATOMO DE HIDROGENO, UN GRUPO ALQUILO SUSTITUIDO POR UNO O MAS ATOMOS DE HALOGENO Y X ES UN ATOMO DE CARBONO O UN ATOMO DE NITROGENO). ASIMISMO SE INCLUYE UNA SAL, HIDRATO O SOLVATO DEL MISMO, ASI COMO UN MEDICAMENTO QUE LO CONTIENE. DICHO COMPUESTO ES UTIL COMO AGENTE ANTIVIRAL FRENTE AL VIRUS DE LA INMUNODEFICIENCIA HUMANA, AL DEL HERPEX SIMPLEX, AL DE LA HEPATITIS B O SIMILARES, Y COMO AGENTE ANTITUMORAL.
ES97934776T 1996-08-13 1997-08-12 Compuestos nucleotidico de fosfonato. Expired - Lifetime ES2186911T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP21369196 1996-08-13

Publications (1)

Publication Number Publication Date
ES2186911T3 true ES2186911T3 (es) 2003-05-16

Family

ID=16643397

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97934776T Expired - Lifetime ES2186911T3 (es) 1996-08-13 1997-08-12 Compuestos nucleotidico de fosfonato.

Country Status (8)

Country Link
US (1) US6194398B1 (es)
EP (1) EP0919562B1 (es)
KR (1) KR20000029952A (es)
CN (1) CN1085673C (es)
CA (1) CA2263286A1 (es)
DE (1) DE69716924T2 (es)
ES (1) ES2186911T3 (es)
WO (1) WO1998006726A1 (es)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005508924A (ja) * 2001-08-30 2005-04-07 三菱ウェルファーマ株式会社 抗ウイルス剤
JP2005511749A (ja) * 2001-12-07 2005-04-28 三菱ウェルファーマ株式会社 Ｂ型肝炎ウィルス感染症を治療するためのホスホネートヌクレオチド類似体の使用
TW200408645A (en) 2002-04-26 2004-06-01 Gilead Sciences Inc Non nucleoside reverse transcriptase inhibitors
US7407965B2 (en) 2003-04-25 2008-08-05 Gilead Sciences, Inc. Phosphonate analogs for treating metabolic diseases
EP1620109A2 (en) 2003-04-25 2006-02-01 Gilead Sciences, Inc. Kinase inhibitor phosphonate conjugates
SG182849A1 (en) 2003-04-25 2012-08-30 Gilead Sciences Inc Antiviral phosphonate analogs
WO2004096285A2 (en) 2003-04-25 2004-11-11 Gilead Sciences, Inc. Anti-infective phosphonate conjugates
US7432261B2 (en) 2003-04-25 2008-10-07 Gilead Sciences, Inc. Anti-inflammatory phosphonate compounds
US7452901B2 (en) 2003-04-25 2008-11-18 Gilead Sciences, Inc. Anti-cancer phosphonate analogs
US7470724B2 (en) 2003-04-25 2008-12-30 Gilead Sciences, Inc. Phosphonate compounds having immuno-modulatory activity
US7427636B2 (en) 2003-04-25 2008-09-23 Gilead Sciences, Inc. Inosine monophosphate dehydrogenase inhibitory phosphonate compounds
WO2005002626A2 (en) * 2003-04-25 2005-01-13 Gilead Sciences, Inc. Therapeutic phosphonate compounds
US7432273B2 (en) 2003-10-24 2008-10-07 Gilead Sciences, Inc. Phosphonate analogs of antimetabolites
WO2005042773A1 (en) 2003-10-24 2005-05-12 Gilead Sciences, Inc. Methods and compositions for identifying therapeutic compounds
WO2005044279A1 (en) 2003-10-24 2005-05-19 Gilead Sciences, Inc. Purine nucleoside phosphonate conjugates
BRPI0417988A (pt) 2003-12-22 2007-04-27 Gilead Sciences Inc análogos de fosfonato antivirais
PT2258376T (pt) 2004-07-27 2019-05-31 Gilead Sciences Inc Análogos fosfonatados de compostos inibidores do vih
WO2007014491A1 (fr) * 2005-08-03 2007-02-08 Beijing Fu Kang Ren Bio-Pharm Tech.Co.Ltd. Phosphonates de nucléotides acycliques et leur utilisation dans des agents antiviraux
EP2244631A4 (en) 2008-01-15 2014-01-22 Nicholas L Taro METHOD AND APPARATUS FOR DETERMINING DETERIORATION OF RESPIRATORY FUNCTION
BRPI0915878A2 (pt) 2008-07-08 2015-11-03 Gilead Sciences Inc sais ou hidratos de compostos inibidores de hiv, seu uso e composição farmacêutica que os compreende
CA2857490C (en) 2011-12-22 2020-03-31 Geron Corporation Guanine analogs as telomerase substrates and telomere length affectors
PT3661937T (pt) 2017-08-01 2021-09-24 Gilead Sciences Inc Formas cristalinas de ((s)-((((2r,5r)-5-(6-amino-9h-purin-9-il)-4-fluoro-2,5-dihidrofurano-2-il)oxi)metil)(fenoxi)fosforil)-l-alaninato de etil (gs-9131) para tratamento de infeções virais
US12606647B2 (en) 2020-07-17 2026-04-21 Dow Global Technologies Llc Hydrocarbyl-modified methylaluminoxane cocatalysts for bis-phenylphenoxy metal-ligand complexes
JP7726977B2 (ja) 2020-07-17 2025-08-20 ダウ グローバル テクノロジーズ エルエルシー 拘束幾何プロ触媒のためのヒドロカルビル変性メチルアルミノキサン助触媒

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0468119A1 (en) * 1990-07-24 1992-01-29 Merrell Dow Pharmaceuticals Inc. Novel carbocyclic analogs of certain nucleosides
JP3580377B2 (ja) * 1993-06-29 2004-10-20 三菱化学株式会社 ホスホナートヌクレオチドエステル誘導体
DE69426904T2 (de) 1993-06-29 2001-10-11 Mitsubishi Chemical Corp., Tokio/Tokyo Phosphonat-Nukleotid Ester-Derivate
TW369536B (en) * 1996-01-18 1999-09-11 Mitsubishi Chem Corp Phosphonate nucleotide compounds

Also Published As

Publication number Publication date
US6194398B1 (en) 2001-02-27
DE69716924D1 (de) 2002-12-12
DE69716924T2 (de) 2003-03-20
CN1232466A (zh) 1999-10-20
CN1085673C (zh) 2002-05-29
EP0919562A1 (en) 1999-06-02
KR20000029952A (ko) 2000-05-25
WO1998006726A1 (en) 1998-02-19
EP0919562A4 (en) 1999-10-13
EP0919562B1 (en) 2002-11-06
CA2263286A1 (en) 1998-02-19

Similar Documents

Publication Publication Date Title
US5262383A (en) 3-aryl-4-hydroxy- DELTA 3-dihydrofuranone and 3-aryl-4-hydroxy- DELTA 3-dihydrothiophenone derivatives and pesticidal use
CY1105957T1 (el) Χρηση οιστρογονων ενωσεων σε συνδυασμο με ενωσεις προγεστογονου (progestogen) σε θepαπεια ορμονικης αντικαταστασης
MX174018B (es) Composiciones generadoras de gas que contienen nitrotriazolona
NZ503910A (en) Alpha-aryl-N-alkylnitrones and pharmaceutical compositions containing the same
ES2157593T3 (es) Derivados de la adenosina heterociclicos sustituidos en n6.
DE69425574D1 (en) L-2',3'-dideoxy-nukleosidanaloga als anti-hepatitis b-(hbv) und anti-hiv-wirkstoffe
ZA200109995B (en) Nematicidal Trifluorobutenes.
ES2180981T3 (es) Procedimiento para la preparacion de una sal de magnesio de un heterociclo de sulfinilo sustituido.
ATE224909T1 (de) 1-(2-deoxy-2-fluoro-4-thio-beta-d- arabinofuranosyl)-cytosine
DE60112330D1 (en) Pyrazolopyridinderivate
MXPA02011417A (es) 1-aminoalquil-lactamas sustituidas y su uso como antagonistas de receptores muscarinicos.
ES2091069T3 (es) Procedimiento de purificacion de pentafluoroetano.
DE60125040D1 (de) Wässrige Harzzusammensetzung
DE60112200D1 (de) Verfahren zur Herstellung von Carbonyl- oder Hydroxy-Verbindungen
ES2026669T3 (es) Procedimiento para la preparacion y el uso terapeutico de los beta-d-fenil tioxilosidos.
YU22598A (sh) Derivati 5'-dezoksi-citidina
ES2183340T3 (es) Procedimiento para la preparcion de compuestos de 4-bromometil-bifenilo.
BR0108046A (pt) Compostos azol condensados e seu uso como agentes hipoglicêmicos
ATE161717T1 (de) Antivirale mittel
PE63696A1 (es) Compuesto quimico
BR9708418A (pt) Amino-e trifenil-s-triazinas hodroxissubstituídas como estabilizadores
EP0841327A4 (en) Triazole antifungal agent
ZA874563B (en) 2-trifluoromethyl-benzimidazoles
DK0727433T3 (da) Fremgangsmåde til fremstilling af 1-(2'-deoxy-2',2'-difluor-d-ribo-pentofuranosyl)-cytosin ud fra 2-deoxy-2,2-difluor-beta-
BR0004524A (pt) Controle de odor em artigos absorventes